No Data
U.S. To J&J: Don't Target Hospital Drug Discounts -- WSJ
Sector Update: Health Care Stocks Steady Premarket Tuesday
Sector Update: Health Care
A judge in Oregon overturned the verdict of the Johnson & Johnson talcum powder case and ordered a retrial.
On September 17th, according to Reuters, a judge in Oregon overturned a jury's decision to award $0.26 billion in compensation to Johnson & Johnson. The plaintiff in the lawsuit claimed to have developed mesothelioma, a fatal cancer related to asbestos exposure, from inhaling the company's talcum powder. According to a spokesperson for Johnson & Johnson, Judge Katharine von ter Stegge in Portland approved the company's motion to overturn the verdict and ordered a new trial. Written opinions are expected to be released in the next few days. The Vice President of Global Litigation at Johnson & Johnson is responsible for the litigation.
AC Immune Expects $29 Million Milestone Payment From Janssen
This Johnson & Johnson Insider Reduced Their Stake By 37%